PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33616345-9 2021 CRP was positively correlated with HOMA-IR, TC, and AHSG (r = 0.485, 0.331, 0.226, p < 0.05), negatively associated with 25-OH-VD (r = -0.443, p < 0.05), and had no correlation to TG and Hcy (r = 0.019, 0.058, p > 0.05). Technetium 44-46 C-reactive protein Homo sapiens 0-3 32430154-9 2020 LDL-c and TC levels inversely correlated with C-reactive protein and interleukin-6, and positively correlated with the number of lymphocytes in patients. Technetium 10-12 C-reactive protein Homo sapiens 46-64 33254652-9 2020 In addition, urinary copper increased monotonically with plasma CRP elevation, which in turn, was positively associated with TC, TG, and LDL-C and negatively related to HDL-C (all P < 0.05). Technetium 125-127 C-reactive protein Homo sapiens 64-67 33254652-10 2020 Results from 3D mesh graphs demonstrated that increased levels of plasma CRP with higher urinary copper corresponded to higher TC, TG, LDL-C, and lower HDL-C concentrations. Technetium 127-129 C-reactive protein Homo sapiens 73-76 33178875-5 2020 In addition, the levels of IMA, hs-CRP and FIB levels showed a strong link to BMI, WHR, TC, TG, LDL and glycated hemoglobin. Technetium 88-90 C-reactive protein Homo sapiens 35-38 32329054-8 2020 ELISA analysis indicated that CRP expression in prostate adenocarcinoma subjects with TT + TC genotypes was statistically higher than in those with CC genotypes. Technetium 91-93 C-reactive protein Homo sapiens 30-33 32684941-6 2020 Results: There was a significant non-linear relationship between lipid profile (TC, TG, HDL-C, LDL-C) and hs-CRP (P < 0.05). Technetium 80-82 C-reactive protein Homo sapiens 109-112 32684941-8 2020 Compared with medium levels of lipids group, pregnant women with higher levels of TC or TG have higher levels of hs-CRP, and pregnant women with lower levels of TC, HDL-C or LDL-C also have higher levels of hs-CRP in the vitamin D deficient group, and there was a significant correlation between low levels of TG and decreased hs-CRP (adjusted beta for TG: -0.063, 95%CI: - 0.120,-0.007) in the non-vitamin D deficient group. Technetium 82-84 C-reactive protein Homo sapiens 116-119 26857805-6 2016 The subjects with a serum hs-CRP >3 mg/dl had higher TC (P < 0.001), low-density lipoprotein cholesterol (LDL-C, P < 0.001), TG (P < 0.001), fat percentage (P < 0.001), and systolic and diastolic blood pressure (P < 0.001) compared with subjects with a serum hs-CRP <3 mg/dl. Technetium 56-58 C-reactive protein Homo sapiens 29-32 30154879-11 2018 After adjusted for CRP, although per 1-SD increase in TC level was still associated with an increment in 4 % in LVEF, it did not achieve achieve statistic significance. Technetium 54-56 C-reactive protein Homo sapiens 19-22 29362264-6 2018 PRIMARY OUTCOME MEASURES: C-reactive protein (CRP), total cholesterol (TC), LDL cholesterol (LDL-C), HDL-cholesterol (HDL-C), triglycerides (TGL), systolic and diastolic blood pressure (SBP and DBP), body mass index (BMI) and waist circumference (WC). Technetium 10-12 C-reactive protein Homo sapiens 26-44 26329334-4 2015 Changes were most evident in patients with substantial reduction in inflammatory levels (TC +8.2% vs +1.6% and HDL-C +8.3% vs +2.2% in patients with C-reactive protein >= 10 mg/l normalizing upon treatment vs CRP < 10 mg/l throughout treatment period). Technetium 89-91 C-reactive protein Homo sapiens 149-167 25904961-7 2015 Before adjusting for age and BMI, CRP was correlated with LDL (r= 0.16, p= 0.03), total cholesterol (TC) (r= 0.17, p= 0. Technetium 101-103 C-reactive protein Homo sapiens 34-37 18709001-4 2008 The aim of our study was to find out if there are any differences in the CRP levels between patients with normal myocardial perfusion and mild to moderate perfusion defects, detected with 99m-Tc sestamibi gated SPECT MPI. Technetium 188-194 C-reactive protein Homo sapiens 73-76 24586854-10 2014 High sensitivity C-reactive protein (hsCRP) was positively correlated with traditional cardio-metabolic risk factors including waist circumference (r = 0.127, p = 0.05), triglycerides (r = 0.19, p = 0.003) and Total Cholesterol: High Density Lipoprotein ratio (TC:LDL) (r = 0.225, p<0.001). Technetium 261-263 C-reactive protein Homo sapiens 17-35 24587064-11 2014 Serum CRP levels correlated negatively with HDL-C (r = -0.352, P = 0.006) and TC (r = -0.262, P = 0.043). Technetium 78-80 C-reactive protein Homo sapiens 6-9 24149106-4 2014 RESULTS: As a continuous variable, lower serum TC level was found to be significantly associated with male sex, symptomatic tumor, advanced TNM stage, higher nuclear grade, microscopic venous invasion, poor Eastern Cooperative Oncology Group Performance Status, larger tumor size, elevated C-reactive protein level, and lower hemoglobin level. Technetium 47-49 C-reactive protein Homo sapiens 290-308 22121485-9 2012 In comparison to AVFs, the presence of a TC was associated with significantly higher levels of CRP (P = 0.03), IL-6 (P = 0.07), and IP-10 (P = 0.03). Technetium 41-43 C-reactive protein Homo sapiens 95-98 21970714-7 2011 A positive correlation between 24S-OH-Chol/TC ratio and plasma C reactive protein (CRP) levels was found in the whole sample, independent of possible confounders (multiple regression p: 0.04; r2: 0.10). Technetium 43-45 C-reactive protein Homo sapiens 63-81 21970714-7 2011 A positive correlation between 24S-OH-Chol/TC ratio and plasma C reactive protein (CRP) levels was found in the whole sample, independent of possible confounders (multiple regression p: 0.04; r2: 0.10). Technetium 43-45 C-reactive protein Homo sapiens 83-86 21870702-2 2011 MATERIAL AND METHODS: C-reactive protein measurement clinical value was examined by high sensitivity CRP method (hsCRP) and compared to clinical value of other heart attack risk factors: total cholesterol (TC) and cholesterol in HDL fraction (HDL-C), triglycerides (TG) and fibrinogen (FBG). Technetium 206-208 C-reactive protein Homo sapiens 22-40 20716150-5 2010 RESULTS: C-reactive protein correlated negatively with TC (r = -0.184, p = 0.002), more so with HDLc (r = -0.327, p = 0.001) and therefore positively with TC:HDLc ratio (r = 0.204, p = 0.001). Technetium 55-57 C-reactive protein Homo sapiens 9-27 20716150-5 2010 RESULTS: C-reactive protein correlated negatively with TC (r = -0.184, p = 0.002), more so with HDLc (r = -0.327, p = 0.001) and therefore positively with TC:HDLc ratio (r = 0.204, p = 0.001). Technetium 155-157 C-reactive protein Homo sapiens 9-27 20716150-7 2010 Furthermore, the TC:HDLc ratio, but not TC, was positively related to event risk, again most marked in those with elevated CRP. Technetium 17-19 C-reactive protein Homo sapiens 123-126 20929499-9 2010 The magnitude of decrease in CRP correlated with that of BMI, WC, fat mass, TG, TC and LDL-C. Technetium 80-82 C-reactive protein Homo sapiens 29-32 23716069-4 2014 Our hypothesis was that there would be an inverse association between raised CRP levels and both TC and HDL-cholesterol levels. Technetium 97-99 C-reactive protein Homo sapiens 77-80 23716069-8 2014 We identified a significant (p<0.001) biphasic relationship between TC and CRP: TC increased within the healthy CRP range of less than 5 mg/l, but decreased with CRP levels above 10 mg/l. Technetium 71-73 C-reactive protein Homo sapiens 78-81 23716069-8 2014 We identified a significant (p<0.001) biphasic relationship between TC and CRP: TC increased within the healthy CRP range of less than 5 mg/l, but decreased with CRP levels above 10 mg/l. Technetium 71-73 C-reactive protein Homo sapiens 115-118 23716069-8 2014 We identified a significant (p<0.001) biphasic relationship between TC and CRP: TC increased within the healthy CRP range of less than 5 mg/l, but decreased with CRP levels above 10 mg/l. Technetium 71-73 C-reactive protein Homo sapiens 115-118 23716069-8 2014 We identified a significant (p<0.001) biphasic relationship between TC and CRP: TC increased within the healthy CRP range of less than 5 mg/l, but decreased with CRP levels above 10 mg/l. Technetium 83-85 C-reactive protein Homo sapiens 78-81 23716069-8 2014 We identified a significant (p<0.001) biphasic relationship between TC and CRP: TC increased within the healthy CRP range of less than 5 mg/l, but decreased with CRP levels above 10 mg/l. Technetium 83-85 C-reactive protein Homo sapiens 115-118 23716069-8 2014 We identified a significant (p<0.001) biphasic relationship between TC and CRP: TC increased within the healthy CRP range of less than 5 mg/l, but decreased with CRP levels above 10 mg/l. Technetium 83-85 C-reactive protein Homo sapiens 115-118 24849439-11 2014 CRP, IL-6 and TNF-a levels in group A were increased at Tb and Tc (P<0.05 or P<0.01) and significantly higher than those in groups B and C (P<0.05 or P<0.01). Technetium 63-65 C-reactive protein Homo sapiens 0-3 20682616-5 2011 Cross-sectionally, higher C-reactive protein (CRP) levels correlated with lower levels of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol ([HDL-C] P <= .015), whereas lipid ratios did not correlate with CRP. Technetium 109-111 C-reactive protein Homo sapiens 26-44 20682616-5 2011 Cross-sectionally, higher C-reactive protein (CRP) levels correlated with lower levels of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol ([HDL-C] P <= .015), whereas lipid ratios did not correlate with CRP. Technetium 109-111 C-reactive protein Homo sapiens 46-49 20659228-4 2010 Evaluated TC was accompanied by decreased C-reactive protein (CRP). Technetium 10-12 C-reactive protein Homo sapiens 42-60 20659228-4 2010 Evaluated TC was accompanied by decreased C-reactive protein (CRP). Technetium 10-12 C-reactive protein Homo sapiens 62-65 20094057-9 2010 Moreover, the regression coefficient of CRP levels with age was significantly steeper in subjects with the CC genotype than in those with the TC or TT genotype (P=0.028). Technetium 142-144 C-reactive protein Homo sapiens 40-43 16832152-5 2006 There were statistically significant associations between the CRP level and two CRP genotypes; the p value for the T allele of rs3091244 (CT + AT + TT vs. CC + CA + AA) was 0.002 (95% confidential interval [CI], 2.1-24), and the p value for the T allele of rs1130864 (TT + TC vs. CC) was 0.002 (95% CI, 2.1-24). Technetium 273-275 C-reactive protein Homo sapiens 62-65 15667581-9 2005 The association between CRP levels and mortality was independent of potential confounding factors such as age, body-mass index, severity of HF, smoking habits, hypertension and TC levels. Technetium 177-179 C-reactive protein Homo sapiens 24-27 15667581-11 2005 Furthermore, patients with increased CRP and decreased TC (additive predictive effect) phenotype had 11.714-times higher risk (95% CI 2.619-52.385) of being nonsurvivors than patients with low CRP/high TC. Technetium 55-57 C-reactive protein Homo sapiens 193-196 15667581-11 2005 Furthermore, patients with increased CRP and decreased TC (additive predictive effect) phenotype had 11.714-times higher risk (95% CI 2.619-52.385) of being nonsurvivors than patients with low CRP/high TC. Technetium 202-204 C-reactive protein Homo sapiens 37-40 12480587-7 2002 Positive correlation of CRP, however, was observed after fluvastatin treatment with TC/HDL (r=0.62, P=0.041) and Lp(a) (r=0.320, P=0.011), while inverse relations were noted between CRP and HDL (r=-0.288, P=0.023). Technetium 84-86 C-reactive protein Homo sapiens 24-27 12476646-7 2002 TCFAs are more common in patients with high serum total cholesterol (TC) and a high TC to high density cholesterol ratio, in women > 50 years, and in those patients with elevated levels of high sensitivity C-reactive protein. Technetium 0-2 C-reactive protein Homo sapiens 209-227 11128362-3 2000 RESULTS: There was a statistically significant positive crude correlation between C-reactive protein and TC (R = 0.19), TG (R = 0.29), BMI (R = 0.32), glucose (R = 0.11), and uric acid (R = 0.14) (all P < 0.0001). Technetium 105-107 C-reactive protein Homo sapiens 82-100 34596129-2 2021 Incidence of composite ASCVD (myocardial infarction, ischemic stroke, and cardiovascular death) was compared between these 2 groups and factors contributing to the association of TC and ASCVD were evaluated.Patients in the high TC group were older and more likely to have diabetes and have higher C-reactive protein level. Technetium 228-230 C-reactive protein Homo sapiens 297-315 9610529-6 1998 For example, relative risks of future MI among those with high levels of both CRP and TC (RR=5.0, P=0.0001) were greater than the product of the individual risks associated with isolated elevations of either CRP (RR=1.5) or TC (RR=2.3). Technetium 224-226 C-reactive protein Homo sapiens 78-81 9610529-7 1998 In stratified analyses, baseline CRP level was predictive of risk for those with low as well as high levels of TC and the TC:HDL-C ratio. Technetium 111-113 C-reactive protein Homo sapiens 33-36 9610529-7 1998 In stratified analyses, baseline CRP level was predictive of risk for those with low as well as high levels of TC and the TC:HDL-C ratio. Technetium 122-124 C-reactive protein Homo sapiens 33-36 34660338-11 2021 For example, after adjusting for age, sex, comorbidities, smoking, and drinking status, the C-reactive protein level was negatively associated with the TC lipid level (beta (SE) = -0.646 (0.219), p = 0.005). Technetium 152-154 C-reactive protein Homo sapiens 92-110 34239907-7 2021 Similarly, 3rd tertiles of HDL and TC had lower levels of baseline inflammatory markers such as CRP, WBC, and NL ratio using linear regression analysis. Technetium 35-37 C-reactive protein Homo sapiens 96-99 35229896-10 2022 TC, TG, LDL-C, ApoB and high-sensitivity C-reactive protein (hsCRP) at baseline had positive correlation with TC after treatment; ApoB at baseline had positive correlation, while HDL-C and free fat acid (FFA) at baseline had negative correlation with TG after treatment. Technetium 110-112 C-reactive protein Homo sapiens 41-59